Abstract
Ivermectin is one of the most commonly used drugs in pharmacotherapy of parasitic diseases in domestic and wild animals caused by parasitic nematodes and arthropods. However, ivermectin and other avermectins very often produce side-effects in hosts. The most dominant clinical symptom of ivermectin toxicity in domestic and wild animals is CNS depression. In nematodes, the target site of ivermectin’s action is glutamate-gated chloride-channel receptor and GABA receptor. The depressive effect of ivermectin in mammals might include more than one mechanism; therefore, the anticonvulsive effect of ivermectin against convulsions caused by lidocaine and strychnine was evaluated. Ivermectin antagonized lidocaine- and strychnine-induced convulsions in rats, although these have different mechanisms. In the present study, the anticonvulsive ED50 of ivermectin for lidocaine-induced convulsions was 2.44 mg/kg (95% CL 1.67 to 3.57 mg/kg), whereas for convulsions induced by strychnine it was higher at 4.25 mg/kg (95% CL 2.32 to 3.78 mg/kg). At the same time, both anticonvulsive doses are significantly lower then the observed LD50 of ivermectin (18.20 mg/kg). Furthermore, flumazenil (0.1 and 0.2 mg/kg), an antagonist of benzodiazepine receptors, antagonizes just one part of these anticonvulsive effects of ivermectin. Our results show the significant anticonvulsive properties of ivermectin and support the findings that ivermectin in the CNS of mammals produces multiple inhibitory effects, probably through participation in the function of GABA-sensitive and GABA-insensitive chloride channels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- ED50 :
-
median effective dose
- GABA:
-
γ-aminobutyric acid
- LD50 :
-
median lethal dose
References
Adams, R.H., 2001. Veterinary Pharmacology and Therapeutics, 8th edition (Iowa State University Press, Ames, IA), 916–920
Arena, J.P., Liu, K.K., Paress, P.S., Frazier, E.G., Cully, D.F., Mrozik, H. and Schaeffer, M., 1995. The mechanism of action of avermectins in Caenorhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity. The Journal of Parasitology, 81(2), 286–294
Barat, S.A. and Abdel-Rahman, M.S., 1997. Decreased cocaine and lidocaine induced seizures response by dextromethorphan and DNQX in rats. Brain Research, 756(1–2), 179–183
Bourke, C.A., 1995. The clinical differentiation of nervous and muscular locomotor disorders of sheep in Australia. Australian Veterinary Journal, 62(6), 228–234
Brander, G.C., Pugh, D.M., Bywater, R.J. and Jenkins, W.L., 1991. Veterinary Applied Pharmacology and Therapeutics, 5th edition (Baillière Tindall, London)
Campbell, W.C., Fisher, M.H., Stapley, E.O., Albers Schonbreg, G. and Jacob, T.A., 1983. Ivermectin: a potent new antiparasitic agent. Science, 221, 823–828
Costa, E. and Guidotti, A., 1979. Molecular mechanisms in the receptor action of benzodiazepines. Annual Review of Pharmacology and Toxicology, 19, 531–545
Cully, D.F., Vassilatis, D.K., Lin, K.K., Paress, P.S., Van der Ploeg, L.H., Schaeffer, J.M. and Arena, J.P., 1994. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature, 20(371;6499), 707–711
Dawson, G.R., Wafford, K.A., Smith, A., Marshall, G.R., Bayley, P.J., Schaeffer, J.M., Meineke, P.T. and McKernan, R.M., 2000. Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through γ-aminobutyric acid A receptor. The Journal of Pharmacology and Experimental Therapeutics, 250, 1051–1060
Duce, I.R. and Scott, R.H., 1985. Action of dihydroavermectin B on insect muscle. British Journal of Pharmacology, 85, 395–401
Etter, A., Cully, D.F., Liu, K.K., Reiss, B., Vassilatis, D.K., Schaeffer, J.M. and Arena, J.P., 1999. Picrotoxin blockade of invertebrate glutamate-gated chloride channels: subunit depedence and evidence for binding within the pore. Journal of Neurochemistry, 72(1), 318–326
Forshaw, P.J., Lister, T. and Ray, E.D., 2000. The role of voltage-gated chloride channels in type II pyrethroid insecticide poisoning. Toxicology and Applied Pharmacology, 163(1), 1–8
Hardman, J.G., Limbird, L.E. and Gilman, A.G., 2001. Goodman-Gilman’s The Pharmacological Basis of Therapeutics, 9th edn, (The Macmillan Company, London and Toronto)
Home Office Code of Practice, 1997. The Humane Killing of Animals under Schedule 1 to the Animals (Scientific Procedures) Act 1986, (HMSO, London; ISBN 0–10–265397–6)
Ikeda, M., Dohi, T.and Tsujimoto, A., 1982. Inhibition of gamma-aminobutyric acid release from synaptosomes by local anesthetics. Anesthesiology, 58(6), 495–499
Kamijima, M. and Casida, J.E., 2000. Regional modification of [(3)H]ethynylbicycloorthobenzoate binding in mouse brain GABA(A) receptor by endosulfan, fipronil and avermectin B (1a). Toxicology and Applied Pharmacology, 163(2), 188–194
Karns, P.A. and Luther, D.G., 1984. A survey of adverse effects associated with ivermectin use in Louisiana horses. Journal of the American Veterinary Medical Association, 185(7), 782–783
Kubova, H. and Mares, P., 1994. Effects of MK-801 (dizocilpine) and ketamine on strychnine-induced convulsions in rats: comparison with benzodiazepines and standard anticonvulsants. Physiological Research, 43(5), 313–320
Lovell, R.A., 1991. Ivermectin and piperazine toxicoses in dogs and cats. The veterinary clinics of North America. Small Animal Practice, 20(2), 453–468
Ruiz-Gomez, A., Garcia-Calvo, M., Vazquez, J., Marvizon, J.C., Valdivieso, F. and Mayor, F, Jr., 1989. Thermodynamics of agonist and antagonist interaction with the strychnine-sensitive glycine receptor. Journal of Neurochemistry, 52(6), 1775–1780
Saneford, E.S., Rehmtulla, A.J. and Gaylou, K.A., 1998. Ivermectin overdose and toxicosis in neonatal pigs. Parasitology, (Proc. I.P.V.S., Ch.IV), 217
Sawaki, K., Ohno, K., Mijamoto, K., Hirai, S., Yazaki, K. and Kawaguchi, M., 2000. Effects of anticonvulsants on local anaesthetic-induced neurotoxicity in rats. Pharmacology and Toxicology, 86, 59–62
Schonrock, B. and Borman, J., 1993. Activation of Cl− channels by avermectin in rat cultured hippocampal neurons. Naunyn-Schmiedeberg’s Archives of Pharmacology, 348(6), 628–632
Shan, Q., Haddrill, J. and Lynch, J. 2001. Ivermectin, an unconventional agonist of the glycine receptor chloride channel. The Journal of Biological Chemistry, 276(16), 12556–12564
Shenoy, A.K., Miyahara, J.T., Swinyard, E.A. and Kupferberg, H.J., 1982. Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital, and valproate in mice and rats. Epilepsia, 23(4), 399–408
Tallarida, R.J. and Murray, R.B., 1987. Manual of Pharmacologic Calculations, with Computer Programs, 2nd ed. (Springer-Verlag, New York)
Vassilatis, D.K., Elliston, K.O., Paress, P.S., Hamelin, M., Arena, J.P., Schalffer, J.M., Van der Ploeg, L.H. and Cully, D.F., 1997. Evolutionary relationship at the ligand-gated ion channels and the avermectin sensitive glutamate gated chloride channels. Journal of Molecular Evolution, 44(5), 501–508
Yokoyama, M., Benson, K.T., Arakawa, K. and Goto, H., 1992. Effects of flumazenil on intravenous lidocaine-induced convulsions and anticonvulsant property of diazepam in rats. Anesthesia and Analgesia, 75(1): 87–90
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trailović, S.M., Varagić, V.M. The Effect of Ivermectin on Convulsions in Rats Produced by Lidocaine and Strychnine. Vet Res Commun 31, 863–872 (2007). https://doi.org/10.1007/s11259-007-0050-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11259-007-0050-3